Skip to main content

Table 1 Association between LYRM4 mRNA expression and various clinicopathological factors of HBV-related LIHC patients

From: Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma

Variables

LYRM4 mRNA expression

p value

Multivariate analysisa

Low (n = 79)

High (n = 78)

OR

95%

p value

Age, years

 ≤ 54

48

37

0.09

1

Reference

 

 > 54

31

41

 

1.570

0.749–3.288

0.232

Gender

 Male

62

65

0.44

1

Reference

 

 Female

17

13

 

0.700

0.271–1.806

0.461

Preoperative AFP (ng/ml)

 ≤ 200

38

49

0.06

1

Reference

 

 > 200

40

28

 

0.675

0.312–1.461

0.318

TB (µmol/L)

 ≤ 20

77

73

0.43

1

Reference

 

 > 20

2

5

 

2.995

0.457–19.63

0.253

ALT (U/L)

 ≤ 50

50

60

0.91

1

Reference

 

 > 50

29

36

 

0.405

0.170–0.968

0.042

γ-GT (U/L)

 ≤ 60

41

40

1.00

1

Reference

 

 > 60

38

37

 

1.957

0.830–4.615

0.125

HBcAb

 No

5

4

0.98

1

Reference

 

 Yes

74

74

 

1.779

0.356–8.877

0.483

Tumor size (cm)

 ≤ 5

39

36

0.69

1

Reference

 

 > 5

40

42

 

1.382

0.612–3.124

0.436

Tumor number

 Single

58

58

0.89

1

Reference

 

 Multiple

21

20

 

1.226

0.523–2.871

0.639

Tumor thrombus

 No

55

66

0.03

1

Reference

 

 Yes

24

12

 

0.355

0.132–0.957

0.041

Tumor encapsulation

 No

27

17

0.08

1

Reference

 

 Yes

50

59

 

2.345

1.035–5.315

0.041

Tumor differentiation

 High

37

45

0.15

1

Reference

 

 Low

42

32

 

0.771

0.368–1.618

0.492

History of liver cirrhosis

 No

19

27

0.15

1

Reference

 

 Yes

60

51

 

0.519

0.223–1.212

0.130

  1. Pearson Chi-Square test was used to analyze the relationship between LYRM4 mRNA expression and clinicopathological characteristics. Font bold means have statistical significance p < 0.05
  2. aLogistics regression was used to multivariate analysis